safingol has been researched along with Colorectal Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Błachnio-Zabielska, AU; Markowska, AJ; Markowski, AR; Pogodzińska, K; Zabielski, P | 1 |
| Bilchik, AJ; Cabot, MC; Litvak, DA | 1 |
2 other study(ies) available for safingol and Colorectal Neoplasms
| Article | Year |
|---|---|
Diverse Sphingolipid Profiles in Rectal and Colon Cancer.
Topics: Ceramides; Colonic Neoplasms; Colorectal Neoplasms; Humans; Lysophospholipids; Rectal Neoplasms; Sphingolipids; Sphingosine | 2023 |
Modulators of ceramide metabolism sensitize colorectal cancer cells to chemotherapy: a novel treatment strategy.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Camptothecin; Cell Survival; Ceramides; Colorectal Neoplasms; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Fumonisins; Glucosylceramides; Humans; Irinotecan; Morpholines; Protein Kinase C; Sphingolipids; Sphingosine; Tumor Cells, Cultured | 2003 |